NHS logo
NHS logo
Benign prostatic hyperplasia (BPH) is a term used to describe an enlarged prostate, a gland that surrounds the urethra. Excess prostate tissue can affect the flow of urine, making it difficult to empt
People living with sickle cell disease need frequent blood transfusion to manage their condition. Spectra Optia separates and removes sickle shaped red blood cells from patients’ blood and replaces
Thopaz+ is a portable digital chest drain system, allowing patients who have had pulmonary resection, or a collapsed lung need a chest drain to stay mobile during their treatment, reducing drainage ti
Sinusitis is swelling and inflammation of the tissues inside the head and nose, usually caused by infection or growths. Treatment with the XprESS system leads to rapid and sustained improvement in sym
The Health Innovation Network (HIN) Insights team undertook a rapid evaluation into a virtual ward model that was used to treat patients at home, in order to reduce pressures on services that had aris
As part of a commissioned programme of work through the London Digital First Programme, an evaluation of the London regional scale of remote monitoring in care homes will be delivered by the Health In
The Healthy Ageing Team conducted a study to ensure the appropriate diagnosis of Dementia in residential and nursing homes across south London. Project overviewThe Alzheimer’s Society estimates that
The Health Innovation Network (HIN) are working with partners across south London to support care homes to increase the use of deterioration management tools to improve the identification, management,
Individuals living with a serious mental illness, die 15-20 years earlier than the general population, due to a greater risk of poor physical health.*This project focuses on the care that people with
There is limited information on digital maturity in care homes within London. Building on the EoLC Care Home data packs created in 2018 and 2019, our Healthy Ageing and Informatics Teams were commissi
In July 2020, The Health Innovation Network (HIN) was commissioned to deliver a programme to increase use and quality of shared electronic advance/urgent care plans using Co-ordinate my Care (CMC). Th
Did you know that 20% of women experience mental health problems during the perinatal period? Partners can also experience mental health problems during this time. Utilising digital solutions can supp
Mental Health Safety Improvement Programme (MHSIP) a three year national AHSN programme is commissioned by NHS England and NHS Improvement as part of the Patient Safety Strategy. It aims to support me
Project overview The Health Innovation Network (HIN) has been working in partnership with Coordinate My Care (CMC), to explore implementing CMC, an electronic urgent care planning service, in care hom
The Health Innovation Network (HIN) has worked with partners across the two south London Integrated care systems (ICS’s) to expand the provision of Diabetes structured education services to include
The HIN’s ESCAPE-pain team received requests from sites that were eager to pilot ESCAPE-pain classes using a digital platform. The team adapted to meet this need and supported sites to trial virtual
The Health Innovation Network (HIN), in partnership with the End of Life Clinical network for London, secured funding from the NHS England (NHSE) personalisation team to work with Marie Curie nurses t
The HIN partnered with training provider Hayat Consultancy to run a pilot online My Wellbeing training course for care home staff in south London to improve mental wellbeing. This was intended to supp
The Rapid Uptake Products (RUP) programme has been designed to support stronger adoption and spread of proven innovations. It identifies and supports products with NICE approval that support the NHS L
The MedTech Funding Mandate (MTFM) policy aims to support getting effective and innovative medical devices, diagnostics and digital products to patients faster. This mandate will pilot with four forme
Coronary heart disease (CHD) is the world’s number one killer, accounting for 15% of UK deaths in 2019¹. HeartFlow FFRCT analysis provides clinicians with a more efficient pathway for diagnosing CH
Pre-eclampsia (PE) affects approximately three per cent of all pregnancies and is a serious cause of maternal and foetal morbidity. There is no definitive test to help diagnose PE and the only “cure
SecurAcath is a small orange triangular device to afix a PICC or Vascular catheter to the patient by the skin through two subcutaneous hooks. It is on the Innovation and Technology Payment (ITP) progr
GammaCore is a simple-to-use, handheld medical device that enables patients to self-administer discrete doses of non-invasive vagus nerve stimulation (nVNS) therapy to the neck. Project overviewCluste